Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Polycythemia Vera × Aspirin × Clear all

Phase

Phase 2 5 Phase 3 2 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Venous Thromboembolism 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Rectal Diseases 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Myeloproliferative Disorders 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Hematuria 1 Hematoma 1 Gastrointestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Gastrointestinal Diseases 1 Endometrial Neoplasms 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colorectal Neoplasms 1 Colonic Diseases 1 Bone Neoplasms 1 Barrett Esophagus 1

Interventions

ruxolitinib 1 Phlebotomy 1 Panobinostat 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06290765 2025-07-31

PV

PharmaEssentia

Phase 4 Not yet recruiting

Myeloproliferative Disorders, Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡